1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
(
- Contribution to journal › Article
-
Mark
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
(
- Contribution to journal › Article
- 2020
-
Mark
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe : A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
(
- Contribution to journal › Article
-
Mark
Improved infrastructure and support needed for paediatric clinical trials in Sweden
(
- Contribution to journal › Article
-
Mark
Dyskinesia matters
(
- Contribution to journal › Article
- 2018
-
Mark
Mitochondrial medicine. New strategies to evaluate drug toxicity and develop pharmacological protection of the cell’s powerhouse.
2018)(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Societal challenges of precision medicine : Bringing order to chaos
(
- Contribution to journal › Article
-
Mark
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(25). p.6444-6449(
- Contribution to journal › Article
- 2015
-
Mark
Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant
(
- Contribution to journal › Article
- 2011
-
Mark
Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting
(
- Contribution to journal › Scientific review